MX9203197A - Prodrogas de esteres que contienen sulfonato de corticisteroides. - Google Patents

Prodrogas de esteres que contienen sulfonato de corticisteroides.

Info

Publication number
MX9203197A
MX9203197A MX9203197A MX9203197A MX9203197A MX 9203197 A MX9203197 A MX 9203197A MX 9203197 A MX9203197 A MX 9203197A MX 9203197 A MX9203197 A MX 9203197A MX 9203197 A MX9203197 A MX 9203197A
Authority
MX
Mexico
Prior art keywords
prodroges
corticisteroid
sulphonate
esters containing
esters
Prior art date
Application number
MX9203197A
Other languages
English (en)
Spanish (es)
Inventor
Bradley D Anderson
Robert A Conradi
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9203197A publication Critical patent/MX9203197A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX9203197A 1983-01-21 1992-06-26 Prodrogas de esteres que contienen sulfonato de corticisteroides. MX9203197A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/459,742 US4472392A (en) 1983-01-21 1983-01-21 Sulfonate containing ester prodrugs of corticosteroids

Publications (1)

Publication Number Publication Date
MX9203197A true MX9203197A (es) 1992-09-01

Family

ID=23825979

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203197A MX9203197A (es) 1983-01-21 1992-06-26 Prodrogas de esteres que contienen sulfonato de corticisteroides.

Country Status (8)

Country Link
US (1) US4472392A (enExample)
EP (1) EP0120557B1 (enExample)
JP (1) JPS59137500A (enExample)
CA (1) CA1199908A (enExample)
DE (1) DE3478605D1 (enExample)
HK (1) HK43993A (enExample)
MX (1) MX9203197A (enExample)
ZA (1) ZA838826B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1310009C (en) * 1984-03-28 1992-11-10 John Mark Braughler Ester prodrugs of steroids
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
US5446177A (en) * 1984-12-28 1995-08-29 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
US4686214A (en) * 1985-10-30 1987-08-11 Alcon Laboratories, Inc. Anti-inflammatory compounds for ophthalmic use
ATE84300T1 (de) * 1987-07-16 1993-01-15 Upjohn Co Aminosalze von alkan-1,n-dicarbonsaeure-mono-(2sulfato-|thyl)amiden.
CZ171095A3 (en) * 1993-01-08 1996-01-17 Astra Ab Novel steroidal derivatives specific for colon or ilium
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
EP1562627A4 (en) * 2002-08-23 2006-11-02 Mclean Hospital Corp CORTICOSTEROID CONJUGATES AND ITS USES
RU2387646C2 (ru) * 2003-08-29 2010-04-27 Рэнбакси Лабораториз Лимитед Ингибиторы фосфодиэстеразы типа-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
WO2007031838A1 (en) 2005-09-16 2007-03-22 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
EA200900472A1 (ru) * 2006-09-22 2009-10-30 Ранбакси Лабораторис Лимитед Ингибиторы фосфодиэстеразы iv типа
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
SI2089417T1 (sl) * 2006-10-12 2015-04-30 Bhi Limited Partnership Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
SI2124944T1 (sl) * 2007-03-14 2012-05-31 Ranbaxy Lab Ltd Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
CA2716390C (en) * 2008-02-25 2016-08-23 Eyegate Pharma S.A.S. Enhanced delivery of a therapeutic to ocular tissues through iontophoresis
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN116514828A (zh) * 2020-08-21 2023-08-01 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089881A (en) * 1957-10-29 1963-05-14 Schering Corp Sulfocarboxylic acid esters of hydroxylated steroids
US2986559A (en) * 1959-01-07 1961-05-30 Schering Corp Novel therapeutic salts and processes for their manufacture
US3171846A (en) * 1962-07-10 1965-03-02 Erba Carlo Spa Prednisolone-21-double esters
NL124139C (enExample) * 1964-11-04
FR6590M (enExample) * 1967-10-31 1968-12-30
US3609712A (en) * 1969-01-15 1971-09-28 Ibm Insulated gate field effect transistor memory array
US4221787A (en) * 1978-03-28 1980-09-09 Interx Research Corporation Esteramide prodrugs of anti-inflammatory corticosteroids
SU818489A3 (ru) * 1978-10-04 1981-03-30 Шеринг Аг (Фирма) Способ получени кортикоид -21- СульфОпРОпиОНАТОВ или иХ СОлЕй
DE2848423A1 (de) * 1978-11-08 1980-05-29 Merck Patent Gmbh Hydrocortisonester, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
CA1199908A (en) 1986-01-28
HK43993A (en) 1993-05-14
DE3478605D1 (en) 1989-07-13
JPH0226639B2 (enExample) 1990-06-12
EP0120557A2 (en) 1984-10-03
US4472392A (en) 1984-09-18
EP0120557A3 (en) 1985-02-06
JPS59137500A (ja) 1984-08-07
EP0120557B1 (en) 1989-06-07
ZA838826B (en) 1984-07-25

Similar Documents

Publication Publication Date Title
ES288754Y (es) Disposicion de apertura de recipientes.
DK462884D0 (da) Vaegelement
BR8101839A (pt) Conjunto de silencioso
DK423482A (da) Laserinstrument
BR8306394A (pt) Instrumento de escrever
FI841738A7 (fi) Imidazol-etanolestrar.
DK550684D0 (da) Emneholderindretning
DK277785D0 (da) Vaegelement
FR2543111B1 (fr) Boite
ES292404Y (es) Cierre de adorno.
FR2567606B1 (fr) Boite de vitesses mecanique-hydrostatique synchronisee
FI840138A0 (fi) Detergentblandning i partikelform
DE3567866D1 (de) Liquid thioxanthoncarboxilic-acid esters
ATA280981A (de) Selbstschwingender wechselrichter
TR20994A (tr) Gizli
DE3471479D1 (de) Substituted phenoxyalcanoic-acid ester
FR2563187B1 (fr) Boite combinee
DK445584D0 (da) Vaegelement
SE8405517D0 (sv) Prefabricerad skivvegg
FR2546032B1 (fr) Caisse de forcage
ES272052Y (es) Conjunto de envases separables.
BR8305031A (pt) Instrumento cravador de pregos
FR2554316B1 (fr) Variete de potentille
SE8304328D0 (sv) Eldflugan
BR8303729A (pt) Processadora de microfichas